There was a trend of borderline significance toward more hyperstimulation without FHR changes with oral misoprostol (1 trial, 190 women, 8/95 versus 0/95; RR 17.01, 95% CI 1.00 to 290.42).
1
—
—
There was a trend of borderline significance toward more hyperstimulation without FHR changes with oral misoprostol (1 trial, 190 women, 8/95 versus 0/95; RR 17.01, 95% CI 1.00 to 290.42).